Literature DB >> 6688416

Expression of human and Chinese hamster hypoxanthine-guanine phosphoribosyltransferase cDNA recombinants in cultured Lesch-Nyhan and Chinese hamster fibroblasts.

J Brennand, D S Konecki, C T Caskey.   

Abstract

The results presented in this communication demonstrate that hypoxanthine-guanine phosphoribosyltransferase (HPRT) cDNA can be expressed in both Chinese hamster and human fibroblasts deficient in the endogenous gene product at levels permitting normal growth of the transformants. All the elements necessary for this expression are present in a pBR322-derived plasmid containing HPRT cDNA coding sequence and a retroviral long terminal repeat. These molecules function in both species investigated and, at least in the case of the Chinese hamster transformants, are efficient at the single copy level. Although the effects of the presence of intron sequences and a polyadenylation signal within the plasmids have yet to be evaluated, these studies demonstrate that neither is an absolute requirement for expression of HPRT cDNA sequences in cultured mammalian cells. We describe the construction of recombinant plasmids containing wild type human or Chinese hamster HPRT cDNA sequences in tandem with a retroviral LTR which confer the HPRT+ phenotype in HPRT-deficient V79 and Lesch-Nyhan fibroblasts. Both stable and unstable transformants, that expressed HPRT mRNA and protein, were isolated at high frequency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Characterization of three new deletions at the 5' end of the HPRT structural gene.

Authors:  M Wehnert; F H Herrmann
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.

Authors:  T D Palella; L J Silverman; C T Schroll; F L Homa; M Levine; W N Kelley
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

3.  Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3.

Authors:  D Lu; J J Yunis
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

Review 4.  The Jeremiah Metzger lecture. Current status of human gene therapy.

Authors:  W N Kelley; T D Palella
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

5.  Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells.

Authors:  Y Shimizu; B Koller; D Geraghty; H Orr; S Shaw; P Kavathas; R DeMars
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

6.  Identification of a single nucleotide change in the hypoxanthine-guanine phosphoribosyltransferase gene (HPRTYale) responsible for Lesch-Nyhan syndrome.

Authors:  S Fujimori; B L Davidson; W N Kelley; T D Palella
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

7.  High frequency of large spontaneous deletions of DNA in tumor-derived CHEF cells.

Authors:  D A Kaden; L Bardwell; P Newmark; A Anisowicz; T R Skopek; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene.

Authors:  D W Melton; D S Konecki; J Brennand; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Isolation of cDNA clones for the catalytic gamma subunit of mouse muscle phosphorylase kinase: expression of mRNA in normal and mutant Phk mice.

Authors:  J S Chamberlain; P VanTuinen; A A Reeves; B A Philip; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 10.  Molecular biology of herpes simplex virus type 1 latency in the nervous system.

Authors:  I Steiner; P G Kennedy
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.